Customize
Quick Links

Accreditation/
Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 30.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 30.0 Contact Hours.

This activity provides Category I CME and self-assessment credits toward Part 2 of the ABS MOC Program. For more information, please visit http://www.absurgery.org

Main Symposium: Designated for a maximum of 25.5 AMA PRA Category 1 Credits™ (25.5 Contact Hours)
Mini Symposium: Designated for a maximum of 4.5 AMA PRA Category 1 Credits™ (4.5 Contact Hours)

Accreditation/Credit Designation (Mini Symposium)

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 4.5 Contact Hours.

Acknowledgement of Commercial Support

This activity is supported by educational grants from AstraZeneca, Acelity, Celgene Corporation, Daiichi Sankyo, Inc., Eisai, Genomic Health, Inc., Lilly, Merck Sharp & Dohme Corp., Novartis Pharmaceuticals Corporation, Pacira Pharmaceuticals, Inc., Pfizer Inc., and Puma Biotechnology.

For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.

About
Accreditation
Privacy Policy
Terms & Conditions
Executive Board
Journal
Faculty Portal
Contact
Facebook
Twitter
LinkedIn
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2017
Physicians’ Education Resource ®, LLC.
All rights reserved.

35th Annual Miami Breast Cancer Conference®

35th Annual Miami Breast Cancer Conference®


CME Events

Thursday, March 8, 2018
7:15 PM – 8:45 PM
A Better Way to Stop Pain: Experts Discuss Paths Toward Responsible Postsurgical Pain Management
Location: Fontaine Room

Friday, March 9, 2018
7:00 AM – 8:30 AM
Medical Crossfire®: How Do We Leverage PARP Inhibition Strategies in the Contemporary Treatment of Breast Cancer?
Location: Fontaine Room

Saturday, March 10, 2018
7:00 AM – 8:30 AM
Optimizing Outcomes in HER2-Positive Breast Cancer: Emerging Evidence and Practical Strategies in Early-Stage Treatment Settings
Location: Fontaine Room

Sunday, March 11, 2018
7:00 AM – 8:30 AM
Bridging Bench to Bedside: The Potential for Immunotherapeutic Strategies in Breast Cancer
Location: Fontaine Room

 

Non-CME Lunches

Thursday, March 8
12:35 PM – 1:50 PM
Review of the Rationale for TAILORx and the Study Design: What Can We Look Forward To?
Location: Splash 9/10
Speaker - Steven Shak, MD
Sponsored by: Genomic Health

Thursday, March 8
12:35 PM – 1:50 PM
LYNPARZA for the Treatment HER2- gBRCAm Metastatic Breast Cancer for patients previously
Location: Splash 11/12
Speaker - Lauren Carcas, MD
Sponsored by: AstraZeneca

Friday, March 9
12:45 PM – 2:00 PM
A Treatment Option for Patients With HR+/HER2- Advanced or Metastatic Breast Cancer
Location: Splash 9/10
Speaker - Andrew Koustenis
Sponsored by: Lilly Oncology

Friday, March 9
12:45 PM – 2:00 PM
Advances in the Treatment of Early-Stage HER2 Positive Breast Cancer
Location: Splash 11/12
Speaker - Gregory Vidal MD, PhD
Sponsored by: Puma Biotechnology

Saturday, March 10
12:45 PM – 2:00 PM
A Case-Based Discussion of HER2+ Early Breast Cancer Treatment and the Aphinity Trial
Location: Splash 9/10
Speaker - Terry Mamounas, MD, MPH, FACS
Sponsored by: Genentech

Saturday, March 10
12:45 PM – 2:00 PM
Make a First-in-Class Oral Therapy Your Partner of Choice
Location: Splash 11/12
Speaker - Dr. David C Molthrop, MD and Kate A., patient ambassador
Sponsored by: Pfizer







Become a Member

Forgot Password?
Filter By